Cross-Reactive Synbody Affinity Ligands for Capturing Diverse Noroviruses

Nidhi Gupta1, John C Lainson1, Paul E Belcher1

  • 1Biodesign Institute Center for Innovations in Medicine, and ‡Biodesign Institute Center for Immunotherapy, Vaccines, and Virotherapy, and School of Life Sciences, Arizona State University , Tempe, Arizona 85281, United States.

Analytical Chemistry
|June 23, 2017
PubMed
Summary

New synbody ligands effectively detect diverse norovirus strains, offering solutions for tracking and potential therapies. These broadly cross-reactive binders show promise for future diagnostic and therapeutic applications.